Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study

Liebrenz, Michael; Schneider, Marcel; Buadze, Anna; Gehring, Marie-Therese; Dube, Anish; Caflisch, Carlo (2016). Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study. Harm reduction journal, 13(1), p. 1. BioMed Central 10.1186/s12954-015-0090-x

[img]
Preview
Text
art%3A10.1186%2Fs12954-015-0090-x.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (486kB) | Preview

BACKGROUND

High-dose benzodiazepine dependence constitutes a major clinical concern. Although withdrawal treatment is recommended, it is unsuccessful for a significant proportion of affected patients. More recently, a benzodiazepine maintenance approach has been suggested as an alternative for patients' failing discontinuation treatment. While there is some data supporting its effectiveness, patients' perceptions of such an intervention have not been investigated.

METHODS

An exploratory qualitative study was conducted among a sample of 41 high-dose benzodiazepine (BZD)-dependent patients, with long-term use defined as doses equivalent to more than 40 mg diazepam per day and/or otherwise problematic use, such as mixing substances, dose escalation, recreational use, or obtainment by illegal means. A qualitative content analysis approach was used to evaluate findings.

RESULTS

Participants generally favored a treatment discontinuation approach with abstinence from BZD as its ultimate aim, despite repeated failed attempts at withdrawal. A maintenance treatment approach with continued prescription of a slow-onset, long-acting agonist was viewed ambivalently, with responses ranging from positive and welcoming to rejection. Three overlapping themes of maintenance treatment were identified: "Only if I can try to discontinue…and please don't call it that," "More stability and less criminal activity…and that is why I would try it," and "No cure, no brain and no flash…and thus, just for everybody else!"

CONCLUSIONS

Some patients experienced slow-onset, long-acting BZDs as having stabilized their symptoms and viewed these BZDs as having helped avoid uncontrolled withdrawal and abstain from criminal activity. We therefore encourage clinicians to consider treatment alternatives if discontinuation strategies fail.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Legal Medicine > Forensic Psychiatric Services
04 Faculty of Medicine > Service Sector > Institute of Legal Medicine

UniBE Contributor:

Liebrenz, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1477-7517

Publisher:

BioMed Central

Language:

English

Submitter:

Antoinette Angehrn

Date Deposited:

09 Feb 2016 13:43

Last Modified:

05 Dec 2022 14:51

Publisher DOI:

10.1186/s12954-015-0090-x

PubMed ID:

26743909

BORIS DOI:

10.7892/boris.75258

URI:

https://boris.unibe.ch/id/eprint/75258

Actions (login required)

Edit item Edit item
Provide Feedback